Global atopic dermatitis market to reach $22.6 billion by

Portland, OR, Sept. 13, 2022 (GLOBE NEWSWIRE) — According to the report released by Allied Market Research, the Atopic Dermatitis Market generated $5.3 billion in 2021 and is expected to reach $22.6 billion by 2031, growing at a CAGR of 15.1% from 2022 to 2031. changing market trends, market size and estimates, value chain, key investment pockets, drivers and opportunities, competitive landscape and regional landscape. The report is a useful source of information for new entrants, shareholders, early adopters and stockholders in introducing necessary strategies for the future and taking essential actions to significantly strengthen and increase their position in the market.

Download the report (PDF of 245 pages with information, graphs, tables, figures):

Report coverage and details:

Report cover Details
Forecast period 2022–2031
Market size in 2031 $22.6 billion
CAGR 15.1%
Number of pages in the report 293
Segments Covered Drug class, route of administration, distribution channel and region
Drivers Significant increase in demand for innovative biologics and product approvals
Increased investment in healthcare solutions and infrastructure
Opportunities Prevalence of favorable reimbursement policies in emerging countries
Ongoing technological advances
Poor refund policies in developing regions

COVID-19 scenario:

  • The global atopic dermatitis market has witnessed a negative impact due to the presence of lockdowns in many countries during the pandemic. Patients feared being infected with COVID-19.
  • Most patients believed that people with skin diseases were more likely to be infected with COVID-19 than the general population. Thus, patients negatively rated the availability of dermatological treatments during the pandemic.
  • In addition, many medical professionals have focused on prioritizing treatment of COVID-infected patients due to the increase in the number of infection cases.
  • However, rapid advancements in drug development and increasing investment in healthcare are expected to recover market growth.

Specific requirement on COVID-19? Ask our industry expert:

The report offers a detailed segmentation of the global atopic dermatitis market based on drug class, mode of administration, distribution channel, and region. The report provides a comprehensive analysis of each segment and their respective sub-segment using graphical and tabular representation. This analysis can essentially help market players, investors and new entrants to determine and design strategies based on the fastest growing and highest revenue generating segments mentioned in the report.

Based on drug class, the biologics segment held the largest market share in 2021, holding more than four-fifths of the global market, and is expected to maintain its leading status during the forecast period. Also, the same segment should cite the Fastest CAGR of 15.5% during the forecast period. The report also analyzes other market segments such as Calcineurin Inhibitors, PDE-4 Inhibitor, Corticosteroids and others.

Based on the mode of administration, the injectables segment held the dominant market share in 2021, holding more than four-fifths of the global market, and is expected to maintain its leading status during the forecast period. Also, the same segment is expected to quote the fastest CAGR of 15.5% during the forecast period.

Based on the distribution channel, the hospital pharmacy segment held the largest market share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leading status during the forecast period. The online pharmacy segment, on the other hand, is expected to quote the fastest CAGR of 15.9% during the forecast period.

Inquire about purchasing:

According to the region, the North America market held the largest market share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leading status during the forecast period. The Asia-Pacific region, on the other hand, is expected to quote the fastest CAGR of 16.2% during the forecast period.

Key players analyzed in the Global Atopic Dermatitis Market report include AbbVie Inc., Arcutis Biotherapeutics, Inc., Asana Biosciences, Inc., Astellas Pharma, Inc., Bayer AG, Inc., Bristol-Myers Squibb Inc. , Dermavant Sciences, Inc., Eli Lilly and Company, Inc., Galderma, Inc., Incyte Corporation, Inc., Leo Pharma, Inc., Novartis AG, Otsuka Pharmaceuticals Co., Ltd., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi SA, Inc. and Viatris, Inc.

The report analyzes these key players of the global atopic dermatitis market. These market players have effectively used strategies such as joint ventures, collaborations, expansion, new product launches, partnerships, and others to maximize their foothold and prowess in the industry. The report is useful for analyzing recent developments, product portfolio, business performance, and operating segments of major market players.

Avenue Basic Plan | Access to the library | 1 year subscription |

Sign up for the Avenue subscription to access over 12,000 business profiles and over 2,000 niche market research reports for $699 per month, per seat. For one year, the customer must purchase a minimum 2-seat plan.

14-day free trial request:

“We have also published some syndicated market studies in the same field that you may be interested in. Below is the title of the report for your referenceconsidering the impact of Covid-19 on this market which will help you to assess the aftereffects of the pandemic on the short and long term growth trends of this market.

Reports on trends in the healthcare industry (book now with 10% discount + Covid-19 scenario):

Protein Sequencing Market by product and service (reagents and consumables, instruments, analytical products, protein sequencing and other services), technology (mass spectrometry and Edman degradation) and application (academic research, biopharmaceutical research and biotechnology): analysis of Global Opportunities and Industry Forecast, 2021-2030

menstrual cup market by product type (disposable and reusable), material (medical grade silicone, natural rubber and thermoplastic elastomer) and distribution channel (online stores and pharmacies and retail stores): analysis of global opportunities and industry forecasts, 2021-2030

Surgical Mask Market by product (basic surgical mask, anti-fog surgical mask, fluid/splash resistant surgical mask and N95 mask), distribution channel (hospitals and clinics, pharmacies and online stores) and sales channel (business to business, business to customer and Business to Government): Opportunity Analysis and Industry Forecast, 2021-2030

Antibiotics market by class (beta-lactam and beta-lactamase, quinolones, macrolides and others), drug origin (natural, semi-synthetic and synthetic), spectrum of activity (broad-spectrum antibiotic and narrow-spectrum antibiotic) and route of Administration (Oral, Intravenous and Others): Global Opportunities Analysis and Industry Forecast, 2021 – 2030

spirulina market By Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Food & Beverages, Cosmetics, Feed & Others) and Formulation (Powder, Tablet & Capsule, Liquid & Granule, and Gelling Agent): Global Opportunities Analysis and Industry Forecast, 2021-2030

About Us

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “Market research reportsand “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.


Comments are closed.